Followers | 826 |
Posts | 119569 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Monday, January 18, 2016 7:58:50 PM
#msg-119916806
Updates:
MNTA inks 50/50 partnership with MYL for 6 FoBs;
terms of MNTA-MYL partnership meet MNTA’s stated goals;
commentary on MNTA-MYL partnership by FierceBiotech;
why MNTA-MYL partnership does not include (infused) Avastin;
MNTA/BXLT start phase-3 trial of Humira FoB;
MNTA/BXLT report phase-1 bioequivalence data for Humira FoB;
can Abbvie block US Humira FoBs until 2022?;
2016-2017 news flow;
MNTA has strong liquidity position (including $105M expected from MYL in 2016);
3Q15 financial results and CC transcript;
former Biogen executive, Matt Ottmer, named COO;
Brean Capital has $29 price target;
patent trial on 40mg Copaxone scheduled for 9/26/15 (if not mooted by IPC);
new inference that MYL not close to FDA approval of Copaxone ANDA;
CAFC remands Lovenox patent case back to District Court for patent trial; AMPH changes its tune on Court bond;
AMPH files desperation “antitrust” lawsuit against MNTA;
MNTA resumes enrollment in phase-2 Necuparanib trial after protocol change.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM